How I Choose Who to Transplant and Who Not to Transplant for MDS
While stem cell transplant is the only curative option for patients with myelodysplastic syndromes (MDS), there are many patients who are not eligible for this intervention due to considerable toxicity and lack of donor source. Dr. Scott will review indications for transplant in MDS patients including the role of age, prior therapy, and disease severity. He will also discuss the most appropriate way to prepare MDS patients for transplant, the role of conditioning intensity in stem cell transplantation, and the use of alternative donor sources.
Bart L. Scott
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members